ArticleApplied bionics and biomechanics2025
Exploring the Therapeutic Potential of Ginseng in Diabetic Retinopathy: A Network Pharmacology and Molecular Docking Study.
Article in Applied bionics and biomechanics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR), a major cause of vision impairment, results from hyperglycemia-induced retinal microvascular damage. Current therapies mainly address symptoms rather than underlying mechanisms. Ginseng, a traditional medicinal herb with antioxidant and anti-inflammatory properties, may offer therapeutic benefits for DR. This study employed network pharmacology to identify bioactive compounds in ginseng and their potential molecular targets associated with DR. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed significant enrichment in inflammation- and oxidative stress-related pathways, particularly the advanced glycation end product (AGE)-RAGE signaling pathway. A protein-protein interaction (PPI) network identified key targets, and molecular docking and dynamics simulations confirmed strong binding affinities between ginseng compounds and DR-related proteins. These findings suggest ginseng may modulate critical pathways involved in DR progression, offering potential as a natural therapeutic agent.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.